Meridigen Biotech signed the tripartite industry-university cooperation programs with Chi Mei hospital and Southern Taiwan University of Science and Technology on 17th July, 2015. President of Meridigen, Yogi Hsuan pointed that four million industry-academic cooperation fund is a beginning, through the co-work of mesenchymal stem cells research, can cultivate a research group study neural regeneration by stem cells, work together to build Taiwan’s biotechnology talents.

This cooperation program study “Mesenchymal Stem Cells used in Nerve Repair Research and Development Potential” as the theme, to nurture Taiwan Biotech talents, enhance the international competitiveness of domestic pharmaceutical biotechnology industry.

Published on Commercial Times website, Jul. 17 2015